1

2

“Caring for the world, one person at a time…inspires and unites the people of Johnson & Johnson.”

3

Founded 1886 New Brunswick, New Jersey

In a Former Wallpaper Factory

44

Managed forthe Long Term

Broadly Based in Human

Health Care

DecentralizedManagement

Approach

Our Peopleand Values

StrategicFramework

O U R F O U N D AT I O N

O U R S T R AT E G I C P R I N C I P L E S

O U R G R O W T H D R I V E R S

Global Reach /Local Focus

Creating Valuethrough

Innovation

Excellence inExecution

Leadingwith Purpose

Our Aspiration

Our Credo

5

Manage for the Long-Term - Consistent Performance

• 76 Consecutive years of sales increases through 2008

• 30 Consecutive years of adjusted earnings increases*

• 52 Consecutive years of dividend increases**• ~70% of sales from #1 or #2 global market share

position• ~25% of sales from new products introduced in the

past 5 years

6* Non-GAAP: Excludes special items

* * Reflects dividend increases through April 2014

Historical Performance

7

Year100

50

20

10

5

1

Reported Sales Net Income*

10.1%

10.6

8.5

5.5

2.3

6.1

10.5%

14.1

11.5

7.6

4.2

10.7

* Excludes special items Note: Above %’s represent CGR’s

Through 2013 Year-End

Therapeutic Areas Immunology Neuroscience Infectious

Diseases/ Vaccines Oncology Cardiovascular &

Metabolism/Other

Vision Care / Diabetes Global Surgery

Surgical Care Specialty Surgery

Infection Prevention

Cardiovascular Care Global Orthopaedics Diagnostics

PharmaceuticalsMedical Devices &

DiagnosticsConsumer

Business Structure - Segments

Baby Skin Care Oral Care Women’s Health Wound Care OTC/Nutritionals

Consumer – Products marketed to the general public and sold both to retail outlets and distributors.

Pharmaceuticals – Products distributed directly to retailers, wholesalers, and health care professionals for prescription use.

Medical Devices & Diagnostics – Products distributed to wholesalers, hospitals, and retailers used principally in the professional field by physicians, nurses, therapists, hospitals, diagnostic laboratories, and clinics.

8

2013 Sales by Segment

9

Building On Our Foundation Of Growth

$27.4 B41%

$14.4 B21%

$25.4 B38%

$14.4B0.5%*

Total Sales $71.3 BillionOperational Change 7.7%

* Operational change

Note: Excluding the net impact of the Synthes acquisition, WW Operational sales change = 5.2%; MD&D ex. Synthes = 0.1% OPS

Pharmaceutical39%

Medical Devices& Diagnostics

40% Consumer21%

$28.1B12.0%*

$14.7B2.8%*

$28.5B6.1%*

Consumer

10

Women's Health

2013 Consumer Segment Sales & Operational Growth Rates

Skin Care

Sales: $14.7 Billion Ops Change: 2.8%

Baby Care

$1.6 (1%)

$3.7 +3%

$2.3 +5%

$4.0 +7%

OTC

Wound Care / Other*

$1.6 +1%

$1.5 (5%)

Oral Care

Please note: Growth rates represent operational YOY change*Nutritionals is now included in “Wound Care/Other” *Rounded for visual accuracy

$ U.S. Billions

11

Pharmaceuticals 12

13

1. Novartis 21

2. Merck & Co. 16

3. Johnson & Johnson 15 4. Pfizer 14

5. Wyeth 13

6. Bristol-Myers Squibb 11

7. Hoffmann - La Roche 11

8. Lilly 11

9. GlaxoSmithKline 10

10. Abbott 9

Best Drug Companies of the Past 15 Years

*per Forbes Magazine

Based on new molecular entities produced in the last 15 years

Creating Value Through InnovationEnd-to-End Strategy Focused on Five Therapeutic Areas

14

IMMUNOLOGY NEUROSCIENCEINFECTIOUS

DISEASE/VACCINESCARDIOVASCULAR &

METABOLISMONCOLOGY

Inflammatory bowel disease

Alzheimer's Disease

HIV Cardiovascular disease Prostate

Rheumatoid arthritis

Mood disorders HCV Diabetes Lung

Psoriasis Schizophrenia RespiratoryB-Cell

malignancies

Pulmonary Chronic Pain Vaccines

$9.2B

2013 YE Sales

$6.7B $3.5B $4.9B $3.8B

$28.1B

Medical Devices& Diagnostics

15

Medical Devices & Diagnostics

$28.5Billion

2013 Sales Worldwide MD&D Market Rank*

#1

Operational Growth**

6.1%

* Source Internal Data** Ex. Net Synthes 0.1%

16

Medical Devices & Diagnostics Segment2013 Sales & Operational Change

Sales: $28.5 Billion Ops Growth Rate: 6%$ US Billions

Orthopaedics

Diabetes Care

Infection Prevention / Other

Surgical Care

Diagnostics

Vision Care

$9.5+23%

$2.6+4%

$2.9+3%

$2.3(11%)

$2.1 +7%

$6.3 (1%)

$1.9(7%)

Specialty Surgery

Cardiovascular Care

$.90%

Note: Growth rates represent operational YOY change Excluding the net impact of the Synthes acquisition, MD&D Operational change = 0.1% and Orthopaedics Operational change = 2.2%

17

Note: Growth rates represent operational YOY change Excluding the net impact of the Synthes acquisition, MD&D Operational change = 0.1% and Orthopaedics Operational change = 2.2%

Enterprise Growth DriversLeveraging the Power of Our Enterprise

OUR GROWTH DRIVERS

New Models for Innovation

China Strategy High Quality Products

Access to Care

Global Reach /Local Focus

Creating ValueThrough Innovation

Excellence in Execution

Leading with Purpose

Customer Focused Solutions

One Johnson & Johnson

in Southeast Asia

Standardization and Productivity

Engaged Global Team

18

19

Evolving Our Business Model

Contracting & New Solutions Unrivaled Solutions

2014 Through 2018

Innovative Contracting

Integrated Solutions

Supply Chain Solutions

Co-Creation through Strategic Partnership

Risk SharingContract Agreements

Val

ue

R

even

ue

M

arke

t sha

re

PatientEngagement Tools

Clinical Pathway

Programs

Global Reach/Local Focus2013 Johnson & Johnson Sales: $71.3 Billion

55% 45%

* Developed = US; Canada; Australia; Western Europe; Japan; and New Zealand

** Emerging = all other remaining countries

22%

78% Developed*

Emerging**OUS

US

20

Reliable, High-Quality ProductsAn Enterprise Approach

Ensuring our products meet rigorous standardsStrengthening and streamlining Supply ChainImplementing new quality and compliance operating modelSetting new benchmarks formedical safety

Creating Valuethrough

Innovation

Excellence inExecution

21

Access to CareCARE INSPIRES CARETM

Supporting over 500 community programs in more than 60 countries Advancing global health by ensuring access to infectious disease vaccinesSupporting health and wellness

Gateway to a Healthy CommunityTM

Global Reach /Local Focus

22

23

caring for the world…

23

…one person at a time.

24

Our Credo We believe our first responsibility is to the doctors, nurses and patients,to mothers and fathers and all others who use our products and services.In meeting their needs, everything we do must be of high quality. We must constantly strive to reduce our costs in order to maintain reasonable prices. Customers’ orders must be serviced promptly and accurately. Our suppliers and distributors must have an opportunity to make a fair profit.

We are responsible to our employees, the men and women who work with us throughout the world. Everyone must be considered as an individual. We must respect their dignity and recognize their merit. They must have a sense of security in their jobs. Compensation must be fair and adequate, and working conditions clean, orderly and safe. We must be mindful of ways to help our employees fulfill their family responsibilities. Employees must feel free to make suggestions and complaints. There must be equal opportunity for employment, development and advancement for those qualified. We must provide competent management, and their actions must be just and ethical.

We are responsible to the communities in which we live and work and to the world community as well. We must be good citizens—support good works and charities and bear our fair share of taxes. We must encourage civic improvements and better health and education. We must maintain in good order the property we are privileged to use, protecting the environment and natural resources.

Our final responsibility is to our stockholders. Business must make a sound profit. We must experiment with new ideas. Research must be carried on, innovative programs developed and mistakes paid for. New equipment must be purchased, new facilities provided and new products launched. Reserves must be created to provide for adverse times. When we operate according to these principles, the stockholders should realize a fair return.

25